Vitamin D and Resistance Exercise in Elderly (NUTRIAGINGVitD)

Vitamin D and Resistance Exercise in Elderly

The aim of this randomized, double-blind, controlled intervention study with parallel groups is to investigate the effect of resistance training (2x/week for 10 weeks) with and without different goals of vitamin D intake on muscle strength, function and mass, oxidative stress parameters and the immune system in community dwelling persons. Participants (n = 100) will be community-dwelling older adults. After a preparticipation screening and a vitamin D blood investigation (vitamin D status below 75 nmol/L) participants will be distributed randomly but stratified by sex, age and initial vitamin D plasma levels to one of the 3 groups (Vitamin D daily + strength training, Vitamin D monthly + strength training, no Vitamin D + strength training).

Study participants are eligible if they are male or female with an age between 65 and 85 years and if their cognitive status as well as their physical fitness level allows to participate at the strength training sessions. Exclusion criteria comprise chronic diseases which contraindicate the training sessions, serious cardiovascular disease, diabetic retinopathy and manifest osteoporosis, a frailty index at or above 3, medication with anticoagulants or cortisone drugs, a regular strength training during the last six months and a vitamin D plasma concentration of 75nmol/L or above.

Primary outcome measure is the change in the handgrip strength. Secondary outcome measures comprise anthropometric data, functional performance tests, immunological and oxidative stress parameters, DNA/Chromosomal damage microbiota, metabolomics and the nutritional status.

Study Overview

• Status: Unknown
• Conditions: Aging
• Intervention / Treatment: Other: Strength Training and Vitamin D monthly; Other: Strength Training and Vitamin D daily; Other: Strength Training and no Vitamin D

• Study Type: Interventional
• Enrollment (Actual): 100
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Austria
  • Vienna, Austria, 1090
    • University of Vienna

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years to 85 years (Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Males and females between the age of 65 and 85 years
• Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State >23)
• Independently mobile

Exclusion Criteria:

• Chronic diseases, which contraindicate a training participation
• Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias)
• Diabetic retinopathy
• Manifest osteoporosis
• Regular use of cortisone-containing drugs
• Regular strength training (> 1x / week) in the last 6 months before inclusion
• Vitamin D plasma level of 75 nmol/l or above

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Strength Training and Vitamin D monthly; Four weeks of Vitamin D (50.000 IU once per month) followed by a 10 week guided resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D intake remains. Over the whole study period participants get 400 mg calcium/day.	Other: Strength Training and Vitamin D monthly; For 4 wks 50.000 IU vitamin D is given as a monthly dose together with daily 400mg of calcium. Both as a supplement, followed by a 10 weeks resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D and calcium intake remain.
Experimental: Strength Training and Vitamin D daily; Four weeks of Vitamin D (800 IU once per day) followed by a 10 week guided resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D intake remains. Over the whole study period participants get 400 mg calcium/day.	Other: Strength Training and Vitamin D daily; For 4 wks 800 IU vitamin D is given as a daily dose together with daily 400mg of calcium. Both as a supplement, followed by a 10 weeks resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D and calcium intake remain.
Experimental: Strength Training and no Vitamin D; Four weeks of no vitamin D administration followed by a 10 week guided resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D intake remains. Over the whole study period participants get 400 mg calcium/day.	Other: Strength Training and no Vitamin D; For 4 wks no vitamin D is administered, followed by a 10 weeks resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the also no vitamin D is given. Over the whole study period participants get 400 mg calcium/day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from baseline in handgrip strength (kg)	Handgrip strength of the right hand will be measured to the nearest kilogram (kg) using a hand Dynamometer. Participants will be encouraged to perform a maximal contraction within approximately 4 to 5 s. After a rest of 60 s, participants will be asked to perform a second trial. The highest score of maximum voluntary contraction will be used for data analyses.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from baseline in chair stand test (repetitions within 30s)	The maximum number of completed cycles of unsupported chair rises (from a seated to a fully erected position (hip and knees straightened)) completed within 30 s is counted automatically (Leonardo Mechanography). Force, acceleration, power, kinetic energy, potential energy, mass, total duration, time per iteration are reported as secondary parameters.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in muscle mass with BIA (kg)		baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in 6min walking test (distance in meter)	Participants are instructed to walk alone as quickly as possible (without running) around a 30 m shuttle course as many times as possible within the time limit of 6 mins.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in the composition of gut-microbiota	Gene sequencing of the 16S rRNA on the stool samples are performed to identify the microbes down to genus level as well as the microbial diversity and relative abundance.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in stool short-chain fatty acids (SCFAs)	The stool short-chain fatty acids (SCFAs) will be extracted and quantitatively analysed by gas chromatography.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in oxidative stress marker such as malondialdehyde	The investigators will consider changes in plasma concentrations of oxidative stress marker such as malondialdehyde.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in inflammatory marker (i.g. IL-6, TNF-alpha)	The investigators will consider changes in plasma concentrations of Interleukin 1 (IL-1), IL-6, IL-8, IL-10, TNF-alpha	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in the metabolomic response	The metabolomic response (ie all metabolites) to the interventions will be analyzed using both nuclear magnetic resonance (NMR) and mass spectrometry (MS) techniques. Patterns of metabolites will be evaluated with statistical techniques, ie discriminant analysis and principal component analysis.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in the amino acid pattern	The plasma amino acid pattern will be assessed with HPLC-MS.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in DNA damage (%DNA in the tail)	DNA damage will be assessed in lymphocytes, whole blood and urine in response to the interventions.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in chromosomal damage (number of micronuclei/1000 binucleated cells)	Chromosomal damage will be assessed in lymphocytes in response to the interventions.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)
Change from baseline in RDA and DNA gene expression	RNA and DNA gene expression will be assessed in response to the interventions.	baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks)

Collaborators and Investigators

• Sponsor: University of Vienna

Study record dates

Study Major Dates

• Study Start (Actual): January 15, 2019
• Primary Completion (Actual): August 20, 2019
• Study Completion (Anticipated): December 1, 2021

Study Registration Dates

• First Submitted: April 7, 2020
• First Submitted That Met QC Criteria: April 7, 2020
• First Posted (Actual): April 10, 2020

Study Record Updates

• Last Update Posted (Actual): April 13, 2020
• Last Update Submitted That Met QC Criteria: April 9, 2020
• Last Verified: April 1, 2020

More Information

Terms related to this study

• Keywords: aging; vitamin D; resistance training
• Additional Relevant MeSH Terms: Physiological Effects of Drugs; Micronutrients; Bone Density Conservation Agents; Calcium-Regulating Hormones and Agents; Vitamin D; Cholecalciferol; Vitamins; Ergocalciferols
• Other Study ID Numbers: FA219002_2

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No